139 related articles for article (PubMed ID: 2828145)
1. Pancreatic cholera syndrome due to a vasoactive intestinal polypeptide-producing tumor: further insights into the pathophysiology.
Rood RP; DeLellis RA; Dayal Y; Donowitz M
Gastroenterology; 1988 Mar; 94(3):813-8. PubMed ID: 2828145
[TBL] [Abstract][Full Text] [Related]
2. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.
Kane MG; O'Dorisio TM; Krejs GJ
N Engl J Med; 1983 Dec; 309(24):1482-5. PubMed ID: 6316136
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cholera: is the diarrhea due to VIP?
Field M; Chang EB
N Engl J Med; 1983 Dec; 309(24):1513-5. PubMed ID: 6316137
[No Abstract] [Full Text] [Related]
4. Effect of vasoactive intestinal peptide in man.
Krejs GJ
Ann N Y Acad Sci; 1988; 527():501-7. PubMed ID: 2839086
[No Abstract] [Full Text] [Related]
5. Vasoactive intestinal peptide secreting tumors. Pathophysiological and clinical correlations.
Bloom SR; Yiangou Y; Polak JM
Ann N Y Acad Sci; 1988; 527():518-27. PubMed ID: 2839088
[No Abstract] [Full Text] [Related]
6. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
[TBL] [Abstract][Full Text] [Related]
7. Increased tear secretion in pancreatic cholera: a newly recognized symptom in an experiment of nature.
Gilbard JP; Dartt DA; Rood RP; Rossi SR; Gray KL; Donowitz M
Am J Med; 1988 Oct; 85(4):552-4. PubMed ID: 2845780
[No Abstract] [Full Text] [Related]
8. Metastatic vipoma arising from colonic primary tumour.
Bradley C; Haddock G; Pickard RG; Rankin EM
Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
[TBL] [Abstract][Full Text] [Related]
9. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
11. [Vasoactive intestinal peptide-producing tumor (ViPoma)].
Doi R; Tsukada T
Nihon Rinsho; 2006 Sep; Suppl 3():358-62. PubMed ID: 17022564
[No Abstract] [Full Text] [Related]
12. Successful treatment of therapy-resistant pancreatic cholera with human leucocyte interferon.
Oberg K; Alm G; Lindström H; Lundqvist G
Lancet; 1985 Mar; 1(8431):725-7. PubMed ID: 2857998
[TBL] [Abstract][Full Text] [Related]
13. [The Verner-Morrison syndrome: endocrine cholera or vipoma? (author's transl)].
Charleux H
Nouv Presse Med; 1982 Mar; 11(11):859-62. PubMed ID: 6280131
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin and analogues in the treatment of VIPoma.
O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
[No Abstract] [Full Text] [Related]
15. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide-secreting tumours (vipomas) in childhood.
Long RG
J Pediatr Gastroenterol Nutr; 1983; 2(1):122-6. PubMed ID: 6310076
[No Abstract] [Full Text] [Related]
17. Multiple endocrine neoplasia, type 1, with pancreatic cholera.
Namihira Y; Achord JL; Subramony C
Am J Gastroenterol; 1987 Aug; 82(8):794-7. PubMed ID: 2886044
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
19. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
Santangelo WC; Dueno MI; Krejs GJ
Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
[No Abstract] [Full Text] [Related]
20. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
[No Abstract] [Full Text] [Related]
[Next] [New Search]